Literature DB >> 29597222

Clinical Complications of Continuous Renal Replacement Therapy.

Florent Sigwalt, Axelle Bouteleux, François Dambricourt, Théo Asselborn, Florent Moriceau, Thomas Rimmelé.   

Abstract

The various complications of continuous renal replacement therapy (CRRT) are mostly preventable. Hemodynamic disturbances are dominated by hypotension due to the modification of volume status, myocardial dysfunction, cardiac arrhythmia, or modification of systemic vascular resistances, which are correlated with body temperature changes. Metabolic complications remain at the forefront and have profoundly changed with the use of regional citrate anticoagulation (RCA). RCA may lead to two distinct situations: citrate overload and citrate accumulation, respectively, responsible for metabolic alkalosis and metabolic acidosis. Electrolyte imbalance is also a classic occurrence with RCA. The chelation of cations by citrate results in hypocalcemia and hypomagnesemia in case of inappropriate substitution. Hemorrhagic complications have been drastically reduced mostly for two reasons: the use of systematic ultrasound guidance for the insertion of dialysis catheters and the use of RCA instead of systemic heparin anticoagulation. Hypothermia induced by CRRT and complications associated with prolonged bed rest are also better controlled today. Finally, the removal of undesired substances remains a major issue, especially when it comes to antibiotics, vitamins and micronutrients, molecules for which the intake should be adapted in case of CRRT.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2018        PMID: 29597222     DOI: 10.1159/000485608

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  6 in total

Review 1.  Continuous Renal Replacement Therapy: Who, When, Why, and How.

Authors:  Srijan Tandukar; Paul M Palevsky
Journal:  Chest       Date:  2018-09-25       Impact factor: 9.410

2.  Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapy.

Authors:  C Warnar; E Faber; P A Katinakis; T Schermer; P E Spronk
Journal:  J Clin Monit Comput       Date:  2021-05-15       Impact factor: 1.977

3.  Clinical effect and safety of continuous renal replacement therapy in the treatment of neonatal sepsis-related acute kidney injury.

Authors:  Cheng Cai; Gang Qiu; Wenchao Hong; Yunlin Shen; Xiaohui Gong
Journal:  BMC Nephrol       Date:  2020-07-18       Impact factor: 2.388

4.  Ultrasound dynamic monitoring of IVCD to guide application of CRRT in patients with renal failure combined with acute heart failure.

Authors:  Guang Yu; Shaoyu Tao; Yingzhi Jin; Wanxia Li; Zanqun Hu; Xiaowei Fang
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

5.  Impact of protocolized fluid management on electrolyte stability in patients undergoing continuous renal replacement therapy.

Authors:  Song In Baeg; Junseok Jeon; Danbee Kang; Soo Jin Na; Juhee Cho; Kyunga Kim; Jeong Hoon Yang; Chi Ryang Chung; Jung Eun Lee; Wooseong Huh; Gee Young Suh; Yoon-Goo Kim; Dae Joong Kim; Hye Ryoun Jang
Journal:  Front Med (Lausanne)       Date:  2022-08-31

6.  Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study.

Authors:  Harin Rhee; Brendan Berenger; Ravindra L Mehta; Etienne Macedo
Journal:  Am J Kidney Dis       Date:  2021-03-30       Impact factor: 11.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.